Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An International 7-Week, Double-Blind, Placebo-Controlled, 2-Parallel Group Study to Assess the Efficacy of Dianicline 40 mg BID as an Aid to Smoking Cessation in Cigarette Smokers

NCT00356967 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT00356967
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00356967 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An International 7-Week, Double-Blind, Placebo-Controlled, 2-Parallel Group Study to Assess the Efficacy of Dianicline 40 mg BID as an Aid to Smoking Cessation in Cigarette Smokers
Lead sponsor
Sanofi
Phase
Phase 3
Overall status
Completed
Start date
June 30, 2006
Completion date
June 30, 2007
Enrollment
602 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

smoking